Integra Scoops up JNJ's Codman Neurosurgery for $1.05 Billion
Integra hopes this deal will grow its revenue to $2 billion sooner than expected.
Integra Lifesciences (IART) - Get Report has acquired Johnson & Johnson's (JNJ) - Get Report neurosurgery medical device unit for $1.045 billion. Integra hopes this deal will grow its revenue to $2 billion sooner than expected. Stocks are pretty stable this a.m. in response. The deal is Integra's second this year.
It acquired a dermatology company in January. Johnson & Johnson is looking to divest its diabetes care assets still.
This article was written by a staff member of TheStreet.
